SSTR1 and cancer: Downregulation of SSTR1 in patients with PCa whose disease is progressing while on ARSIs is consistent with the known antitumor effect of somatostatin (56) and somatostatin analogs (57, 58) observed in other cancer types (e.g., gastrointestinal and pancreatic NE tumors).